Press Release

India Animal Vaccine Market to Reach $ 232 Million by 2026

Increase in number of diseases in animals is driving India animal vaccine market

According to TechSci Research report, India Animal Vaccine Market By Animal Type, By Technology, By Disease, By Route of, By Distribution Channel, Competition, Forecast & Opportunities, FY 2026, India animal vaccine market is forecast to cross $ 232 million by FY 2026. With rising availability of chicken, eggs and other poultry products, the requirement of maintaining the quality and health of these products has also increased, which is leading to growth in the country’s animal vaccine market. Moreover, advances in inactive vaccine technology are expected to bode well for India animal vaccine market through the forecast period. Furthermore, increasing consumption of meat and animals is driving the animal vaccine market in the country. Along with this, supportive government funding, reimbursement policies and increasing investments by public and private bodies is expected to fuel the market growth over the next five years. However, there are some factors that can act as major impediments to the growth of India animal vaccine market through FY 2026 such as concerns pertaining to reimbursement policies and regulatory scenarios.

Browse more than 9 market data Figures spread through 75 Pages and an in-depth TOC on "India Animal Vaccine Market "

 

https://www.techsciresearch.com/report/india-animal-vaccine-market/5013.html

 

India animal vaccine market is segmented on the basis of animal type, technology, disease, route of administration, distribution channel, and region. Based on animal type, the market is segmented into livestock, swine, poultry, companion animals, and others. Livestock segment dominates the market, followed by swine and poultry segments. In terms of technological segmentation, the inactive vaccine segment accounts for the largest share in India animal vaccine market and is further anticipated to maintain its dominance during the forecast period as well. Other prominent technology segments in the country’s animal vaccine market include Live Attenuated Vaccine, Toxoid Vaccine and Recombinant Vaccine segments.

In term of route of administration, the market is segregated into Subcutaneous, Intramuscular, Intraocular, Oral and others. Out of these, subcutaneous segment accounted for largest market share until FY 2020 and is further anticipated to grow at a high pace in the years to come. Zoetis, Inc., Elanco India Private Limited, Merck & Co., Inc., Ceva Sante Animale SA, Bio-med, Inc, Globion India Private Limited, Biovet Private Limited, Brilliant Bio Pharma Pvt Ltd, Hester Biosciences Limited, Indovax Pvt. Ltd. are among the leading players operating in India animal vaccine market. Market players are adopting several growth strategies to enhance animal vaccine market.

Download sample report @ https://www.techsciresearch.com/sample-report.aspx?cid=5013

customers can also request for 10% free customization on this report.

“Considering the distribution channels, veterinary hospitals continue to dominate the animal vaccine market in India, with veterinary clinics standing at a distant second. Both the segments grabbed around 80% of animal vaccines sales in the country in FY 2020, with pharmacies accounting for the remaining sales. This trend is expected to prevail over the course of next five years” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

India Animal Vaccine Market By Animal Type, By Technology, By Disease, By Route of, By Distribution Channel, Competition, Forecast & Opportunities, FY 2026has evaluated the future growth potential of India animal vaccine market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India animal vaccine market.

 Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

 

Tel: +1-646-360-1656

 

Email: [email protected]

Relevant News